Russell Investments Group, Ltd. - TREACE MED CONCEPTS INC ownership

TREACE MED CONCEPTS INC's ticker is TMCI and the CUSIP is 89455T109. A total of 125 filers reported holding TREACE MED CONCEPTS INC in Q1 2023. The put-call ratio across all filers is 0.12 and the average weighting 0.2%.

Quarter-by-quarter ownership
Russell Investments Group, Ltd. ownership history of TREACE MED CONCEPTS INC
ValueSharesWeighting
Q3 2023$223
-100.0%
17
-100.0%
0.00%
-100.0%
Q2 2023$7,244,024
-13.2%
283,191
-14.5%
0.01%
-12.5%
Q1 2023$8,343,655
+8.5%
331,229
-1.0%
0.02%0.0%
Q4 2022$7,691,118
-7.7%
334,542
-11.4%
0.02%
-11.1%
Q3 2022$8,334,000377,6820.02%
Other shareholders
TREACE MED CONCEPTS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Soleus Capital Management, L.P. 1,907,823$25,011,5602.31%
FORMULA GROWTH LTD 222,269$2,913,9470.99%
EMERALD MUTUAL FUND ADVISERS TRUST 1,193,939$15,652,5400.94%
EMERALD ADVISERS, LLC 1,473,281$19,314,7130.94%
Perceptive Advisors 1,834,060$24,044,5270.80%
NEXT CENTURY GROWTH INVESTORS LLC 512,738$6,721,9950.73%
OBERWEIS ASSET MANAGEMENT INC/ 355,600$4,661,9160.50%
Novo Holdings A/S 360,000$4,719,6000.35%
TimesSquare Capital Management, LLC 1,433,429$18,7920.29%
KORNITZER CAPITAL MANAGEMENT INC /KS 677,733$8,885,0800.18%
View complete list of TREACE MED CONCEPTS INC shareholders